Mark McMackin

Mark McMackin is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as a Senior Principal Technical Representative at Eli Lilly and Company since July 2023, focusing on Clinical Trial Drug Product Supply. Previously held roles include CQV Engineer at both Merck Group and Lilly Limerick, as well as positions at MeiraGTx, Pfizer, and Regeneron Pharmaceuticals in various capacities related to tech transfer, validation, and biotech production. Mark's educational background includes a Bachelor's Degree in Biotechnology from the University of Galway and ongoing postgraduate studies in Digital Transformation at Griffith College Dublin.